Bossage Genetics
VC Fund
Bossage Genetics is a VC fund focused on Medical and Biotechnology. Bossage Genetics invests in Pharmaceutical companies.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Bossage Genetics invests in
Stages Bossage Genetics invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Product Research 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity. | $14.4M / Series A / May 13, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bossage Genetics invest in?
Bossage Genetics invests primarily in Medical, Biotechnology and Product Research startups, most often at Series A stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bossage Genetics last invest?
The most recent investment recorded for Bossage Genetics closed in May 2023. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!